Strategic Information for the Life Science and Analytical Instrument Industry
In a recently published report, Strategic Directions International (SDi), IBO’s publisher, provides an overview of the fast-growing Chinese analytical instrument and lab product market. The report, “China 2021: The Market for Laboratory Analytical & Life Science Instruments,” includes forecast and market segmentation details for ten categories of laboratory technologies (see below). China’s investment in R&D, […]
As one of the fastest growing segments of the biopharma market, cell and gene therapies (CGT) are creating a new era of medical treatments. Making cell and gene therapies possible are genetic manipulation and cell growth and maintenance. To accomplish these tasks in R&D, quality control and manufacturing, scientists are drawing on established laboratory tools […]
A new report from the US Congressional Budget Office (CBO) provides a snapshot of the US pharmaceutical industry and its R&D patterns. The report also explains the important role that the federal government plays in drug development and sales. Here, IBO gives an overview of the data presented in the report on pharmaceutical sales and […]
Bioprocessing International (BPI) US West 2021 kicked off its virtual edition this morning, Monday March 29. An annual event, BPI West encompasses presentation, posters and networking events focused on the latest developments in bioprocessing and cell and gene therapy. A talk this morning, “Integration of Paperless Benchtop Instruments in Clinical Manufacturing,” presented by Simon Barskyi […]
The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]
Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]
With US regulatory emergency use authorization (EUA) of two vaccines, a major threshold has been crossed in the response to COVID-19. According to the latest information, dated December 16, from the World Health Organization (WHO), more SARS-CoV-2 vaccine candidates are moving closer to completing the clinical trial phase. Twenty percent of the candidates in clinical […]
This month, the European University Association, a representative of more than 800 European universities, issued a new report, “Public Funding Observatory 2020/2021: Part 1: Financial and economic impact of the COVID-19 crisis on universities in Europe.” The report is based on a survey conducted this summer of 29 national European university associations. The report illustrates […]
As the stock market continues its gyrations this year in the face of the unprecedented circumstances of COVID-19 and subsequent macroeconomic downtown, how are life science tool companies’ stocks doing? One way to answer this question is to look at companies that have completed IPOs over the past two years. New to the public market […]
